We have begun reviewing claims involving Lipitor which is a member of the drug class known as statins. It is prescribed to reduce cholesterol. Parke-Davis Pharmaceutical Research, a division of Warner-Lambert Company, obtained approval from the Food and Drug Administration (FDA) to market Lipitor on December 17, 1996. Warner-Lambert entered into a co-marketing agreement with…
